|Bid||243.14 x 1000|
|Ask||243.27 x 800|
|Day's range||239.46 - 243.64|
|52-week range||189.40 - 301.34|
|Beta (5Y monthly)||0.47|
|PE ratio (TTM)||45.97|
|Earnings date||11 Aug 2022|
|Forward dividend & yield||1.68 (0.69%)|
|Ex-dividend date||11 May 2022|
|1y target est||244.33|
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, you...
NuVasive (NUVA) delivered earnings and revenue surprises of -14.55% and 1.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Acquisition lays foundation to build ResMed’s digital sleep medicine portfolio in Germanysomnio digital health application focused on improving sleep in patients with diagnosed insomnia, filling care gap and providing alternative to prevailing drug therapy mementor to be integrated into ResMed in Germany as a separate business segment and will serve as a platform for further developments in the field of digital health MARTINSRIED, Germany and LEIPZIG, Germany, Aug. 02, 2022 (GLOBE NEWSWIRE) -- R